Masimo: Deep Dive Analysis

3 months ago

HatedMoats

"MASI: Med-tech turnaround w/ dominant pulse oximetry moat. New mgmt post-activist campaign refocusing on core after divesting Sound United consumer unit. 2025E EPS $5.20-5.45 (+25-30% growth), op margins expanding to ~27% from cost cuts. $1.76B contract backlog provides visibility. Trading 24x forward P/E vs peers at 28x+. Bull case sees $280-300 on innovation success; bear case $100 on stalled growth. Base case $200-235 in 3-5yrs. 60% probability to outperform S&P 500. Strong Buy <$120."

Related Stocks